Hassan Bukhari

Hassan Bukhari

Auto-generated profile, based on publicly available information

Hassan Bukhari

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Molecular Biochemistry, Cell Signalling, Ruhr-University Bochum, Bochum, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Trends in Cell Biology
Verified
Journal Article
Closed access
HBHassan Bukhari
Hassan Bukhari
TMThorsten Müller
Thorsten Müller

1 September 2017 in Progress in Neurobiology
Verified
Journal Article
Closed access
HBHassan Bukhari
Hassan Bukhari
AGAnnika Glotzbach
Annika Glotzbach
KKKatharina Kolbe
Katharina Kolbe
GLGregor Leonhardt
Gregor Leonhardt
CLChristina Loosse
Christina Loosse
TMThorsten Müller
Thorsten Müller

29 May 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CHCaroline Holtkamp
Caroline Holtkamp
BKBjörn Koos
Björn Koos
MUMatthias Unterberg
Matthias Unterberg
Tim RahmelTim Rahmel
Tim Rahmel
LBLars Bergmann
Lars Bergmann
KRKatharina Rump
Katharina Rump
Propofol is a widely used anaesthetic drug with advantageous operating conditions and recovery profile. However, propofol could have long term effects on neuronal cells and is associated with post-operative delirium (POD). In this context, one of the contributing factors to the pathogenesis of POD is a reduction of cholinesterase activity. Accordingly, we investigated the effects of propofol on the methylation, expression and activity of cholinergic genes and proteins in an in-vitro model. We found that propofol indeed reduced the activity of AChE / BChE in our in-vitro model, without affecting the protein levels. Furthermore, we could show that propofol reduced the methylation of a repressor region of the CHRNA7 gene without changing the secretion of pro–or anti-inflammatory cytokines. Lastly, propofol changed the expression patterns of genes responsible for maintaining the epigenetic status of the cell and accordingly reduced the tri-methylation of H3 K27. In conclusion we found a possible functional link between propofol treatment and POD, due to a reduced cholinergic activity. In addition to this, propofol changed the expression of different maintenance genes of the epigenome that also affected histone methylation. Thus, propofol treatment may also induce strong, long lasting changes in the brain by potentially altering the epigenetic landscape.

14 August 2016 in Cellular Signalling
Verified
Journal Article
Closed access
HBHassan Bukhari
Hassan Bukhari
KKKatharina Kolbe
Katharina Kolbe
GLGregor Leonhardt
Gregor Leonhardt
CLChristina Loosse
Christina Loosse
ESElisabeth Schröder
Elisabeth Schröder
TMThorsten Müller
Thorsten Müller

1 December 2016 in Neurobiology of Aging
Verified
Journal Article
Closed access
KKKatharina Kolbe
Katharina Kolbe
HBHassan Bukhari
Hassan Bukhari
CLChristina Loosse
Christina Loosse
GLGregor Leonhardt
Gregor Leonhardt
AGAnnika Glotzbach
Annika Glotzbach
TMThorsten Müller
Thorsten Müller

1 January 2016 in Cellular Signalling
Verified
Journal Article
Closed access
CLChristina Loosse
Christina Loosse
MPMagdalena Pawlas
Magdalena Pawlas
HBHassan S.S. Bukhari
Hassan S.S. Bukhari
AMAbdelouahid Maghnouj
Abdelouahid Maghnouj
SHStephan Hahn
Stephan Hahn
TMThorsten Müller
Thorsten Müller